Marcie A. Goldstein

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount…

Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…

Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of Sienna Biopharmaceuticals, Inc., including shares sold pursuant to…

Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…

Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of Akcea Therapeutics, Inc., including shares sold pursuant to the…

Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500 shares of common stock of Loxo Oncology, Inc. The common stock is…

Davis Polk advised the representatives of the underwriters in connection with the $356.5 million initial public offering of 20,970,589 shares of common stock of WideOpenWest, Inc., which…